Daniel Arias
Stock Analyst at Stifel
(5.00)
# 13
Out of 5,240 analysts
165
Total ratings
55.91%
Success rate
143.15%
Average return
Main Sectors:
Stocks Rated by Daniel Arias
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALMR Alamar Biosciences | Initiates: Buy | $28 | $23.01 | +21.69% | 1 | May 12, 2026 | |
| RVTY Revvity | Maintains: Hold | $110 → $100 | $95.01 | +5.25% | 3 | May 6, 2026 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $700 → $600 | $446.03 | +34.52% | 18 | Apr 24, 2026 | |
| TXG 10x Genomics | Maintains: Buy | $20 → $25 | $21.07 | +18.65% | 8 | Mar 2, 2026 | |
| GH Guardant Health | Maintains: Buy | $120 → $130 | $98.47 | +32.02% | 6 | Feb 20, 2026 | |
| QGEN Qiagen | Maintains: Hold | $45 → $50 | $32.70 | +52.91% | 5 | Feb 6, 2026 | |
| TECH Bio-Techne | Maintains: Hold | $60 → $65 | $44.89 | +44.80% | 12 | Feb 5, 2026 | |
| ILMN Illumina | Maintains: Buy | $135 → $155 | $145.00 | +6.90% | 17 | Jan 20, 2026 | |
| BLLN BillionToOne | Initiates: Buy | $145 | $90.59 | +60.06% | 1 | Dec 1, 2025 | |
| MTD Mettler-Toledo International | Maintains: Buy | $1,450 → $1,600 | $1,025.53 | +56.02% | 8 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $48 → $40 | $43.85 | -8.78% | 9 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $14 → $12 | $7.87 | +52.48% | 10 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $260 | $165.99 | +56.64% | 10 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $9 | $1.02 | +782.35% | 2 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $6 | $7.54 | -20.42% | 2 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $45 → $65 | $45.90 | +41.61% | 2 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $332 → $360 | $334.93 | +7.49% | 16 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $163 → $151 | $112.74 | +33.94% | 20 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $10 | $4.37 | +128.83% | 2 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $165 → $207 | $107.03 | +93.40% | 9 | Feb 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $5 | $2.50 | +100.00% | 2 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $28 → $10 | $5.30 | +88.68% | 2 | May 31, 2022 |
Alamar Biosciences
May 12, 2026
Initiates: Buy
Price Target: $28
Current: $23.01
Upside: +21.69%
Revvity
May 6, 2026
Maintains: Hold
Price Target: $110 → $100
Current: $95.01
Upside: +5.25%
Thermo Fisher Scientific
Apr 24, 2026
Maintains: Buy
Price Target: $700 → $600
Current: $446.03
Upside: +34.52%
10x Genomics
Mar 2, 2026
Maintains: Buy
Price Target: $20 → $25
Current: $21.07
Upside: +18.65%
Guardant Health
Feb 20, 2026
Maintains: Buy
Price Target: $120 → $130
Current: $98.47
Upside: +32.02%
Qiagen
Feb 6, 2026
Maintains: Hold
Price Target: $45 → $50
Current: $32.70
Upside: +52.91%
Bio-Techne
Feb 5, 2026
Maintains: Hold
Price Target: $60 → $65
Current: $44.89
Upside: +44.80%
Illumina
Jan 20, 2026
Maintains: Buy
Price Target: $135 → $155
Current: $145.00
Upside: +6.90%
BillionToOne
Dec 1, 2025
Initiates: Buy
Price Target: $145
Current: $90.59
Upside: +60.06%
Mettler-Toledo International
Nov 10, 2025
Maintains: Buy
Price Target: $1,450 → $1,600
Current: $1,025.53
Upside: +56.02%
Aug 5, 2025
Maintains: Hold
Price Target: $48 → $40
Current: $43.85
Upside: -8.78%
Aug 4, 2025
Maintains: Hold
Price Target: $14 → $12
Current: $7.87
Upside: +52.48%
Mar 14, 2025
Upgrades: Buy
Price Target: $260
Current: $165.99
Upside: +56.64%
Mar 12, 2025
Maintains: Buy
Price Target: $11 → $9
Current: $1.02
Upside: +782.35%
Nov 13, 2024
Maintains: Buy
Price Target: $17 → $6
Current: $7.54
Upside: -20.42%
Nov 11, 2024
Downgrades: Hold
Price Target: $45 → $65
Current: $45.90
Upside: +41.61%
Nov 4, 2024
Maintains: Hold
Price Target: $332 → $360
Current: $334.93
Upside: +7.49%
May 30, 2024
Maintains: Buy
Price Target: $163 → $151
Current: $112.74
Upside: +33.94%
Feb 23, 2024
Maintains: Buy
Price Target: $11 → $10
Current: $4.37
Upside: +128.83%
Feb 22, 2024
Maintains: Buy
Price Target: $165 → $207
Current: $107.03
Upside: +93.40%
Aug 14, 2023
Maintains: Buy
Price Target: $9 → $5
Current: $2.50
Upside: +100.00%
May 31, 2022
Maintains: Hold
Price Target: $28 → $10
Current: $5.30
Upside: +88.68%